Research Analysts Offer Predictions for BCAX FY2025 Earnings
Bicara Therapeutics Inc. (NASDAQ:BCAX – Free Report) – Investment analysts at Cantor Fitzgerald increased their FY2025 earnings estimates for Bicara Therapeutics in a report issued on Monday, March 31st. Cantor Fitzgerald analyst E. Schmidt now expects that the company will earn ($1.81) per share for the year, up from their prior estimate of ($2.50). Cantor […]
Bicara Therapeutics Inc. (NASDAQ:BCAX – Free Report) – Investment analysts at Cantor Fitzgerald increased their FY2025 earnings estimates for Bicara Therapeutics in a report issued on Monday, March 31st. Cantor Fitzgerald analyst E. Schmidt now expects that the company will earn ($1.81) per share for the year, up from their prior estimate of ($2.50). Cantor […]
